Member Log-in

I forgot my password

Not a Member? Register

Return on Investment from Immunization

Sachiko Ozawa, Samantha Clark, Allison Portnoy, Simrun Grewal, Logan Brenzel, and Damian G. Walker

An important research article was published in Health Affairs in February 2016, quantifying the “return on investment” from investments in immunization. The analysis covered 94 low and middle income countries, including all 73 Gavi countries. It uses projected coverage rates for 10 antigens from 2011 to 2020.

The key finding was that the net benefits of immunization were 16 times the projected costs. The analysis was also disaggregated by specific antigen. For all antigens, the net benefit was greater than one, indicating that net benefits exceed projected costs. Projected costs include vaccines, service delivery and supply chain costs. Projected benefits include averted treatment and transportation costs, lost caretaker wages, and productivity losses. This approach is called the “cost of illness” approach.
The analysis also used a second methodology which captures the intrinsic value that people place on living longer and healthier lives from immunization. The return on investment was larger, coming in at $44, with this methodology.

You can read the article here. If you have trouble accessing the full article, please reach out to the LNCT Network Coordinators.

You May Also Like

TVEE Publishes Open Source Health Economics Courses on OpenCourseWare

The Teaching Vaccine Economics Everywhere (TVEE) project is pleased to announce that three modules from its vaccine economics curriculum are now available to the public for free on the JHSPH OpenCourseWare (OCW). The modules published are Health Economics for Vaccines, Costing in Vaccine Planning and Programming, and Economic Evaluation and are available here. Anybody can … Continued

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Continued

New Guide Helps Countries Assess Immunization Financing Options

Helen Saxenian, Cheryl Cashin, and Paul Wilson, Results for Development Maintaining high rates of immunization coverage, which is essential for a persistent reduction in the incidence of vaccine-preventable infectious diseases, requires a sufficient and sustained investment. In order to ensure that governments are making adequate investments in immunization financing and are doing so through sustainable … Continued

Choose a Language